Khalife Jade, Ammar Walid, El-Jardali Fadi, Emmelin Maria, Ekman Björn
Department of Clinical Sciences, Malmö, Faculty of Medicine, Lund University, Malmö, Sweden.
Higher Institute of Public Health, Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.
BMC Health Serv Res. 2024 Dec 5;24(1):1551. doi: 10.1186/s12913-024-12045-1.
The objective of this paper was to estimate the impact of country-wide hospital pay-for-performance on readmissions for a set of common conditions in Lebanon.
This retrospective cohort study included all hospitalizations under the coverage of the Ministry of Public Health in Lebanon between 2011 and 2019. We calculated 30-day all-cause readmissions following general, pneumonia, cholecystectomy and stroke cases. We used an interrupted time series design, including the use of AutoRegressive Integrated Moving Average models. This nationwide study including 1,333,691 hospitalizations was undertaken in Lebanon, using hospitalizations at about 140 private and public hospitals contracted by the Ministry. The participants included citizens across all ages under the Ministry's coverage (52% of citizens). The intervention was the engagement of hospital leaders by the Ministry, informing them of the addition of a readmissions component to the ongoing pay-for-performance initiative. Engagement participants included hospital directors and managers, and the leadership of the Syndicate of Private Hospitals. The main outcome measure was age-adjusted monthly all-cause readmission rates for each of general, pneumonia, cholecystectomy and stroke cases. We also assessed for change in readmissions for three conditions not included in the intervention (myocardial infarction, cataract surgery and appendectomy).
Across 2011-2019, the overall readmission rates were 6.00% (SD 0.24%) for general readmissions, 5.06% (SD 0.22%) for pneumonia, 2.54% (SD 0.16%) for cholecystectomy, and 6.55% (SD 0.25%) for stroke. Using ARIMA models we found a relative percentage decrease in mean monthly readmissions in the post-intervention period for cholecystectomy (5.9%; CI 0.1%-11.8%) and stroke (13.6%; CI 3.1%-24.2%). There was no evidence of intervention impact on pneumonia and general readmissions, both overall and among small, medium and large hospitals. There was also no evidence of change in non-P4P readmissions of myocardial infarction, cataract surgery and appendectomy.
Including readmissions within pay-for-performance has the potential to improve hospital performance and patient outcomes, even in countries with more limited resources. Effects may vary across conditions, indicating the need for careful design and understanding of the particular context, both with respect to implementation and to evaluation of impact.
本文的目的是评估黎巴嫩全国范围内医院绩效薪酬制度对一系列常见疾病再入院率的影响。
这项回顾性队列研究纳入了2011年至2019年黎巴嫩公共卫生部覆盖范围内的所有住院病例。我们计算了普通疾病、肺炎、胆囊切除术后和中风病例后的30天全因再入院率。我们采用了中断时间序列设计,包括使用自回归积分滑动平均模型。这项在黎巴嫩进行的全国性研究涵盖了1333691例住院病例,研究对象为卫生部签约的约140家私立和公立医院的住院患者。参与者包括卫生部覆盖范围内所有年龄段的公民(占公民总数的52%)。干预措施是卫生部让医院领导参与其中,告知他们在现行的绩效薪酬计划中增加了再入院率这一组成部分。参与人员包括医院院长和管理人员以及私立医院协会的领导层。主要结局指标是普通疾病、肺炎、胆囊切除术和中风病例各自经年龄调整后的每月全因再入院率。我们还评估了干预措施未涉及的三种疾病(心肌梗死、白内障手术和阑尾切除术)的再入院率变化。
在2011年至2019年期间,普通疾病再入院的总体再入院率为6.00%(标准差0.24%),肺炎为5.06%(标准差0.22%),胆囊切除术为2.54%(标准差(0.16%),中风为6.55%(标准差0.25%)。使用自回归积分滑动平均模型,我们发现干预后胆囊切除术的平均每月再入院率相对下降了5.9%(置信区间0.1%-11.8%),中风下降了(13.6%;置信区间3.1%-24.2%)。没有证据表明干预措施对肺炎和普通疾病的再入院率有影响,无论是总体上还是在小型、中型和大型医院中。也没有证据表明心肌梗死、白内障手术和阑尾切除术在非绩效薪酬相关的再入院率方面有变化。
将再入院率纳入绩效薪酬制度有可能提高医院绩效和患者治疗效果,即使在资源较为有限的国家也是如此。不同疾病的效果可能有所不同,这表明在实施和评估影响时,需要精心设计并了解具体情况。